• Profile
Close

Size and location are the most important risk factors for malignant behavior in resected solitary fibrous tumors

Annals of Surgical Oncology Oct 20, 2017

Gholami S, et al. - Researchers sought to delineate the prognostic factors for recurrence and disease-specific death (DSD) in resected primary solitary fibrous tumors (SFTs). They recognized marked association of recurrence with DSD and events occurred as late as 16 years after initial presentation, including in patients with initially considered benign tumors. The greatest risk was observed for patients with large (≥ 8 cm) tumors in the chest or abdominal/retroperitoneal cavity.

Methods

  • Researchers identified resected primary SFTs from 1982 to 2015 from a prospective, single institutional database.
  • They assessed risk factors for local (LR) and distant recurrence (DR), and DSD using competing risk analysis.

Results

  • This study included 219 patients; median follow-up of 6.1 (0.1–22) years was performed.
  • Findings revealed five- and 10-year cumulative DSD of 9 and 11%, respectively.
  • DSD seemed to have significant correlation with size greater than the median 8 cm, gender, location, and complete gross resection(p < 0.05).
  • LR had five- and 10-year cumulative risk (CR) of 4 and 7%.
  • However, 5- and 10-year CR of DR was 13 and 16%, respectively.
  • LR seemed to have correlation with location (p = 0.02) and tumor size (p = 0.02); DR seemed to have correlation with size (p < 0.01).
  • Histopathologic classification was not predictive of long-term behavior with both malignant and benign tumors demonstrating capacity for DR and associated death.
  • The greatest risk of DR was observed for tumors in the thoracic cavity and abdomen/retroperitoneum (16 and 27% 10-year CR).
  • Multivariate analysis suggested that size ≥ 8 cm (hazard ratio 2.89, p = 0.05) and tumor location in chest or abdominal/retroperitoneal cavity (hazard ratio 2.68, p = 0.01) markedly impacted DSD.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay